|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Primary prevention of colorectal cancer:Myth or reality?显示文摘Colorectal cancer incidence has been rising strongly in parallel with economic development.In the past few decades,much has been learned about the lifestyle,dietary and medication risk factors for this malignancy.With respect to lifestyle,compelling evidence indicates that prevention of weight gain and maintenance of a reasonable level of physical activity can positively influence in lowering the risk.Although there is controversy about the role of specific nutritional factors,consideration of dietary pattern as a whole appears useful for formulating recommendations.Though quite often recommended,the role for many supplements,including omega-3,vitamin D,folate,and vitamin B6,remains unsettled.Only calcium and vitamin D supplementation appear to add a modest benefit,particularly in those with a low daily intake.With regard to chemoprevention,medications such as aspirin and nonsteroidal antiinflammatory drugs,and postmenopausal hormonal replacement for women might be associated with substantial reductions in colorectal cancer risk,though their utility is affected by their side effect profile.However,the role of agents such as statins,bisphosphonates and antioxidants have yet to be determined.Ultimately,primary prevention strategies focusing on modifying environmental,lifestyle risk factors,and chemopreventive drugs are options that have already been tested,and may impact on colon cancer incidence. | Marcela Crosara Teixeira Maria Ignez Braghiroli Jorge Sabbaga Paulo M Hoff | 2014 | World Journal of Gastroenterology2014，20，41： | 5 |
| 2 | Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results显示文摘 | Angelita Habr-Gama Rodrigo Oliva Perez Wladimir Nadalin Jorge Sabbaga Ulysses Ribeiro Afonso Henrique Silva e Sousa Fábio Guilherme Campos Desidério Roberto Kiss Joaquim Gama-Rodrigues | 2004 | Annals of Surgery2004，，4： | 2 |
| 3 | Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? 显示文摘 | Habr-Gama A Sabbaga J Gama-Rodrigues J | 2013 | Dis Colon Rectum2013，56，10： | 1 |
| 4 | Bevacizumab : overview of the literature显示文摘 | Braghiroli MI Sabbaga J Hoff PM | 2012 | Expert Review of Anticancer Therapy2012，12，5： | 1 |
| 5 | Bevacizumab: overview of the literature 显示文摘 | Braghiroli MI Sabbaga J Hoff PM | 2012 | Expert Rev Anticancer Ther2012，12，5： | 1 |
| 6 | Detection of HSV nucleic acid sequences in the cornea during acute and latent ocular disease 显示文摘 | Sabbaga EM Pavan-Langston D Bean KM | 1988 | Exp Eye Res1988，47，4： | 1 |
| 7 | Bevacizumab:overview of the literature显示文摘 | Braghiroli MI Sabbaga J Hoff PM | 2012 | Expert Rev Anticancer Ther2012，12，5： | 1 |
| 8 | Haemodialysis without anticoagulant: Haemostasis parameters, fibrinogen kinetic, and di alysis efficiency显示文摘 | Romfio JE Jr Fadil MA Sabbaga E | 1997 | Nephrol Dial Transplant1997，12，： | 1 |
| 9 | Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results显示文摘 | Angelita Habr-Gama Rodrigo Oliva Perez Wladimir Nadalin Jorge Sabbaga Ulysses Ribeiro Afonso Henrique Silva e Sousa Fábio Guilherme Campos Desidério Roberto Kiss Joaquim Gama-Rodrigues | 2004 | Annals of Surgery2004，，4： | 1 |
| 10 | Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer:are we getting closer to anal cancer management显示文摘 | Habr-Gama A Sabbaga J Gama-Rodrigues J | 2013 | Dis Colon Rectum2013，56，： | 1 |
| 11 | Bevacizumab: overview of the literature显示文摘 | Braghiroli M I Sabbaga J Hoff P M | 2012 | Expert Rev Anticancer Ther2012，12，5： | 1 |
| 12 | Haemodialysis without anticoagulant:haemostasis parameters,fibrinogen kinetic,and dialysis efficiency显示文摘 | Romao JE Jr Fadil MA Sabbaga E | 1997 | Nephrol Dial Transplant1997，12，1： | 1 |
| 13 | Hemodialysis without anticoagulant hamostasis parameters,fibrinogen kinetik,and dialysis efficiency显示文摘 | ROMAOJR J E FADIL M A SABBAGA E | 1997 | Nephrol Dial Transplant1997，12，： | 1 |
| 14 | Bevacizumab: overview ff the lit- erature显示文摘 | Braghiroli MI Sabbaga J Hofl' PM | 2012 | Expert Rev Anticancer Ther2012，12，5： | 1 |
| 15 | Acute acalculous cho Leeystitis in a patient with metastatic renal cell carcinoma treated with sunitinib显示文摘 | DA FONSECA LG BARROSO-SOUSA R SABBAGA J | 2014 | Clin Pratt2014，4，63： | 1 |
| 16 | Bevacizumab : overview of theLiterature显示文摘 | Braghiroli MI Sabbaga J Hoff PM | 2012 | Expert Rev Anticancer Ther2012，12，5： | 1 |
| 17 | Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing显示文摘 | De Lima JJ Sabbaga E Vieira ML | 2003 | Hypertension2003，42，3： | 1 |
| 18 | Bladder irrigation with amphotericin B and funga| urinary tract infection-systematic review with meta-analysis 显示文摘 | FELIPE FRANCISCO TUON VALDIR SABBAGA AMATO SERGIO RICARDO PENTEADO FILHO | 2009 | Intern Infec Dis2009，13，： | 1 |
| 19 | Fast and slow methylators: do racial differences influence risk of allograft rejection显示文摘 | Chocair PR Duley JA Sabbaga E | 1993 | Q J Med1993，86，6： | 1 |
| 20 | Bevacizumab: overview of the literature 显示文摘 | Braghiroli M I Sabbaga J Hoff P M | 2012 | Expert Rev Anticancer Ther2012，12，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员